Ruihao Zhang

Title: The Innovative Contributions of Ruihao Zhang

Introduction

Ruihao Zhang is a prominent inventor based in Taicang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cancer treatment. With a total of 2 patents, his work showcases a commitment to advancing medical science.

Latest Patents

Zhang's latest patents include an ALK kinase inhibitor and a preparation method and uses thereof. This patent describes an ALK kinase inhibitor compound represented by Formula I, along with a pharmaceutical composition containing the compound. It outlines the preparation method and its use in developing drugs that serve as ALK inhibitors for treating cancer. Another notable patent involves cyclopropanecarboxamido-substituted aromatic compounds as anti-tumor agents. This patent provides details on compounds that inhibit protein kinases, particularly focusing on tyrosine-kinase inhibitors and Raf-kinase inhibitors, along with their preparation and pharmaceutical composition for cancer treatment.

Career Highlights

Throughout his career, Ruihao Zhang has worked with several notable companies, including Crown Bioscience Inc. and Beijing Pearl Biotechnology Limited Liability Company. His experience in these organizations has allowed him to collaborate on various innovative projects aimed at improving cancer therapies.

Collaborations

Zhang has collaborated with several professionals in his field, including Deyi Zhang and Boyu Zhong. These partnerships have contributed to the successful development of his patented inventions.

Conclusion

Ruihao Zhang's contributions to cancer treatment through his innovative patents highlight his role as a significant figure in pharmaceutical research. His work continues to inspire advancements in the medical field.